Inventor
PATIENT LEE
GB17 patents
⚠️ This page may combine multiple inventors who share the name “PATIENT LEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROXIMAGEN LLC
9 patentsUS10590125B2Mar 17, 2020
Compounds
PROXIMAGEN LLC3 citations83
US10428066B2Oct 1, 2019
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LLC6 citations83
US11512082B2Nov 29, 2022
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof
PROXIMAGEN LLC1 citations72
US10968223B2Apr 6, 2021
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LLC1 citations72
US10766897B2Sep 8, 2020
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LLC1 citations72
US10995091B2May 4, 2021
CXCR4 receptor antagonists
PROXIMAGEN LLC3 citations70
US10155761B2Dec 18, 2018
CXCR4 receptor antagonists
PROXIMAGEN LLC4 citations70
US11530208B2Dec 20, 2022
Imidazo[4,5-C]pyridine derived SSAO inhibitors
PROXIMAGEN LLC1 citations62
US10738044B2Aug 11, 2020
Therapeutic compound and use in therapy
PROXIMAGEN LLC0 citations51
PROXIMAGEN LTD
5 patentsUS9676769B2Jun 13, 2017
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LTD11 citations92
US9428498B2Aug 30, 2016
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof
PROXIMAGEN LTD11 citations92
US9951068B2Apr 24, 2018
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LTD8 citations83
US9580415B2Feb 28, 2017
Compounds
PROXIMAGEN LTD9 citations81
US10065954B2Sep 4, 2018
Substituted imidazo[4,5-c]pyridines as SSAO inhibitors
PROXIMAGEN LTD5 citations72